SCLC-TumorMiner: A Directly Accessible Genomics Resource for Precision Oncology: Big Data for Small Cells
Elloumi, F.; Dhall, A.; Taniyama, D.; Luna, A.; Yasuhiro, A.; Varma, S.; Wang, J.; Tehim, A.; Raffeld, M.; Aldape, K.; Redon, C.; Shresta, R.; Reinhold, W.; Aladjem, M. I.; Del Rivero, J.; Roper, N.; Thomas, A.; Pommier, Y.
Show abstract
RNAseq and DNAseq are fast, cost-effective and quantitative methods to dissect cancer cells. However, for each sample, they generate thousands of data points, and comparing patient samples multiplies the complexity. To handle these difficulties, we developed TumorMiner, a web-based tool for clinicians and basic researchers. Here we present our analyses and website for Small Cell Lung Cancer (SCLC). SCLC_TumorMiner includes 235 samples from untreated and relapse patients across the NCI, the University of Rochester, Tongji University and the University of Cologne (https://discover.nci.nih.gov/SclcTumorMinerCDB/). SCLC_TumorMiner allows the molecular classification of tumors based on the canonical NAPY classification and NMF, genomic network analyses exemplified by the Myc and Notch pathways, and the identification of risk-factors and predictive gene expression biomarkers for cell surface and intracellular targets such as DLL3, TROP2, SEZ6, CEA, TRPM5, SLFN11 and proapoptotic and multidrug resistance genes. The architecture of TumorMiner allows its extension to proteomic databases, and to other cancers and institutions worldwide to elucidate cancer pathways, achieve precision medicine and serve as a medical assistant software.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Predicting immunotherapy response in advanced bladder cancer: a meta-analysis of six independent cohorts 96%
- Dissecting tumor cell programs through group biology estimation in clinical single-cell transcriptomics 95%
- Single-Cell RNA Sequencing Reveals the Effects of Chemotherapy on Human Pancreatic Adenocarcinoma and its Tumor Microenvironment 95%
Similar papers in this journal
- EZH2 inhibition promotes tumor immunogenicity in lung squamous cell carcinomas 94%
- Predicting tumor immune microenvironment and checkpoint therapy response of head & neck cancer patients from blood immune single-cell transcriptomics 93%
- Spatial landscape of malignant pleural and peritoneal mesothelioma tumor immune microenvironment 92%
Similar papers in this journal
- "3G" Trial: An RNA Editing Signature for Guiding Gastric Cancer Chemotherapy 94%
- Epigenomic profiling discovers trans-lineage SOX2 partnerships driving tumor heterogeneity in lung squamous cell carcinoma 94%
- Acquired RAD51C promoter methylation loss causes PARP inhibitor resistance in high grade serous ovarian carcinoma 94%
Similar papers in this journal
- Predicting the Tumor Microenvironment Composition and Immunotherapy Response in Non-Small Cell Lung Cancer from Digital Histopathology Images 95%
- Explainable, federated deep learning model predicts disease progression risk of cutaneous squamous cell carcinoma 94%
- Genetic program activity delineates risk, relapse, and therapy responsiveness in Multiple Myeloma 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.